Streetbeat News

Products Services

ASND

Ascendis Pharma's investigational drug TransCon CNP shows promising results in a trial for treating achondroplasia, a form of dwarfism. The drug demonstrated superior growth velocity in children compared to placebo and showed a good safety profile. Ascendis plans to submit an FDA application in early 2025.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 4:18 pm

HYZN

Hyzon Motors shares rose as the company began production of its Class 8 200kW fuel cell electric trucks.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:11 pm

CRM

Salesforce Ventures has announced a new $500 million AI fund, increasing its total commitment to AI innovators to $1 billion. This move highlights Salesforce's focus on AI technology and innovation.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:03 pm

AMZN

EverPass has signed a distribution deal with Amazon to stream NFL's Thursday Night Football on Prime Video, expanding its reach to commercial establishments. This move follows EverPass's previous agreements with Peacock and Charter Communications, and a strategic investment from TKO Group Holdings.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 3:58 pm

DIS

Disney and DirecTV have resolved a two-week blackout, restoring access to Disney's networks, including ESPN and ABC, just as the football season intensifies. The new agreement allows DirecTV customers more flexibility in choosing channel packages and includes options to add Disney's streaming services.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 3:54 pm

BABA

BIDU

NVDA

Alibaba's stock is down due to China's weak economic data and U.S. semiconductor sanctions. The sanctions impact Alibaba's AI ambitions, crucial for its e-commerce and cloud businesses. The Biden administration's tariff hikes on Chinese imports add to the pressure. Barclays suggests policy easing to boost demand.

Portfolio Pulse from Anusuya Lahiri

September 16, 2024 | 3:27 pm

RHHBY

Roche Holdings AG received FDA approval for two subcutaneous injections: Ocrevus Zunovo for multiple sclerosis and Tecentriq Hybreza for various cancers. These approvals offer faster administration times compared to traditional IV methods.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 3:23 pm

AAPL

BTCUSD

TSLA

Bitcoin's price fell below $59,000 despite significant ETF inflows, while the FBI investigates a second assassination attempt on Trump. The S&P 500 and Nasdaq futures are mixed, with potential market corrections seen as buying opportunities. Apple faces lower demand for its iPhone 16 Pro models, and Tesla's Cybertruck sales are strong.

Portfolio Pulse from Akanksha Bakshi

September 16, 2024 | 3:20 pm

BNTX

MRNA

NVAX

PFE

The DeSantis administration in Florida advises against mRNA COVID-19 vaccines for vulnerable individuals, citing rare heart condition risks. This contrasts with federal health agencies' endorsements. Moderna, Pfizer, and Novavax are directly impacted by this guidance.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 3:18 pm

ETHUSD

TRUMP

XRPUSD

Sistine Research shares contrarian views on cryptocurrencies, highlighting potential opportunities in Ripple (XRP), Ethereum (ETH), and the TRUMP meme coin. XRP is seen as undervalued amid its SEC case, while ETH is expected to benefit from DeFi growth. The TRUMP token could surge if Trump wins the election.

Portfolio Pulse from Khyathi Dalal

September 16, 2024 | 3:17 pm